265 related articles for article (PubMed ID: 32208488)
41. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
[TBL] [Abstract][Full Text] [Related]
42. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
Martins M; Bridoux F; Goujon JM; Meuleman MS; Ribes D; Rondeau E; Guerry MJ; Delmas Y; Levy B; Ducloux D; Kandel-Aznar C; Le Fur A; Garrouste C; Provot F; Gibier JB; Thervet E; Bruneval P; Rabant M; Karras A; Dragon Durey MA; Fremeaux-Bacchi V; Chauvet S
Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
[TBL] [Abstract][Full Text] [Related]
44. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.
Kim SS; Patel M; Yum K; Keyzner A
Transfusion; 2015 Feb; 55(2):452-8. PubMed ID: 25209960
[TBL] [Abstract][Full Text] [Related]
45. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.
de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP
Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309
[TBL] [Abstract][Full Text] [Related]
46. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
Dhakal P; Bhatt VR
Bone Marrow Transplant; 2017 Mar; 52(3):352-356. PubMed ID: 27775697
[TBL] [Abstract][Full Text] [Related]
47. Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients.
Rudoni J; Jan A; Hosing C; Aung F; Yeh J
Eur J Haematol; 2018 Sep; 101(3):389-398. PubMed ID: 29920784
[TBL] [Abstract][Full Text] [Related]
48. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
49. Transplant-associated thrombotic microangiopathy: opening Pandora's box.
Gavriilaki E; Sakellari I; Anagnostopoulos A; Brodsky RA
Bone Marrow Transplant; 2017 Oct; 52(10):1355-1360. PubMed ID: 28287636
[TBL] [Abstract][Full Text] [Related]
50. [Advances in Diagnosis and Treatment of Transplant-Associated Thrombotic Microangiopathy --Review].
Geng YK; Wang T; Song ZQ; Yang JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):602-606. PubMed ID: 37096542
[TBL] [Abstract][Full Text] [Related]
51. Approaching treatment of transplant-associated thrombotic Microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus.
Jan AS; Hosing C; Aung F; Yeh J
Transfusion; 2019 Nov; 59(11):3519-3524. PubMed ID: 31587288
[TBL] [Abstract][Full Text] [Related]
52. High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
Jodele S; Dandoy CE; Myers K; Wallace G; Lane A; Teusink-Cross A; Weiss B; Davies SM
Bone Marrow Transplant; 2018 Oct; 53(10):1311-1318. PubMed ID: 29674658
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease.
Bhunia N; Abu-Arja R; Bajwa RPS; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2019 Oct; 66(10):e27912. PubMed ID: 31264793
[TBL] [Abstract][Full Text] [Related]
54. Thrombotic microangiopathy - the importance of a multidisciplinary approach.
Tran MH; Patel S; Desai S; Ciurea S; Lee BJ; Hanna R
Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):247-256. PubMed ID: 38018789
[TBL] [Abstract][Full Text] [Related]
55. Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy.
Ardissino G; Capone V; Tedeschi S; Porcaro L; Cugno M
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890144
[TBL] [Abstract][Full Text] [Related]
56. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.
Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA
Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840
[TBL] [Abstract][Full Text] [Related]
57. Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy.
Gomez-Ganda L; Benitez-Carabante MI; Fernandez-Polo A; Muñoz-Lopez M; Renedo-Miro B; Ariceta G; Diaz De Heredia C
Front Pediatr; 2021; 9():761726. PubMed ID: 34858907
[No Abstract] [Full Text] [Related]
58. Reeling in complement in transplant-associated thrombotic microangiopathy: You're going to need a bigger boat.
Jodele S; Sabulski A
Am J Hematol; 2023 May; 98 Suppl 4():S57-S73. PubMed ID: 36746623
[TBL] [Abstract][Full Text] [Related]
59. Thrombotic Microangiopathy Triggered by COVID-19: Case Reports.
Korotchaeva J; Chebotareva N; Andreeva E; Sorokin Y; McDonnell V; Stolyarevich E; Moiseev S
Nephron; 2022; 146(2):197-202. PubMed ID: 34808629
[TBL] [Abstract][Full Text] [Related]
60. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
